Skip to main content
. 2014 May 12;8(1):17–24. doi: 10.3892/ol.2014.2134

Figure 2.

Figure 2

QYHJ suppresses tumor growth through inhibiting the cell cycle process. (A–C) Cell cycle was analyzed in CFPAC-1,CFPAC-1 control RNAi and CFPAC-1 EphB2 RNAi cells by flow cytometry following QYHJ treatment. (D) QYHJ treatment blocked the cell cycle in the G0/G1 phase and reduced the S phase proportion in CFPAC-1 and CFPAC-1 control RNAi cells. A statistically significant increase was identified in the G0/G1 phase population (P<0.05) and a decrease was identified in the S phase population in CFPAC-1 and CFPAC-1 control RNAi cells, however, no difference was identified in the CFPAC-1 EphB2 RNAi cells following QYHJ treatment (P<0.05). EphB2, erythropoietin-producing hepatoma cell line-B2; QYHJ, Qingyihuaji formula. *P<0.05 compared with the NS group.